Hormone-related risk factors for breast cancer in women under age 50 years by estrogen and progesterone receptor status: results from a case-control and a case-case comparison
It has been suggested that hormonal risk factors act predominantly on estrogen receptor and progesterone receptor (ER/PR)-positive breast cancers. However, the data have been inconsistent, especially in younger women.
Methods
We evaluated the impact of age at menarche, pregnancy history, duration of breastfeeding, body mass index, combined oral contraceptive use, and alcohol consumption on breast cancer risk by ER/PR status in 1,725 population-based case patients and 440 control subjects aged 20 to 49 years identified within neighborhoods of case patients. We used multivariable unconditional logistic regression methods to conduct case-control comparisons overall as well as by
breast cancer risk factors young women, oral contraceptive breast cancer risk, pregnancy breastfeeding breast cancer, hormonal risk breast cancer premenopausal, estrogen receptor breast cancer risk, progesterone receptor breast cancer, reproductive factors breast cancer, birth control pill breast cancer, menarche breast cancer risk, breastfeeding duration cancer protection
Cite this article
Ma, H., Bernstein, L., Ross, R. K., & Ursin, G. (2006). Hormone-related risk factors for breast cancer in women under age 50 years by estrogen and progesterone receptor status: results from a case-control and a case-case comparison. *Breast cancer research : BCR*, *8*(4), R39. https://doi.org/10.1186/bcr1514
Ma H, Bernstein L, Ross RK, Ursin G. Hormone-related risk factors for breast cancer in women under age 50 years by estrogen and progesterone receptor status: results from a case-control and a case-case comparison. Breast Cancer Res. 2006;8(4):R39. doi:10.1186/bcr1514
Ma, H., et al. "Hormone-related risk factors for breast cancer in women under age 50 years by estrogen and progesterone receptor status: results from a case-control and a case-case comparison." *Breast cancer research : BCR*, vol. 8, no. 4, 2006, pp. R39.
Alonso-Molero J et al., 2022Menopause (New York, N.Y.)
Objective: To extend knowledge about the long-term use of hormones in hormone therapy or oral contraception as prognostic factors in breast cancer.
Methods: The MCC-Spain project is a cohort of 1,685 ...
Contraception/Comparison > Side Effects > Hormonal ContraceptionContraception/Comparison > FABM vs Hormonal > Side EffectsGeneral OB/GYN > Epidemiology > Trends
To investigate the sociological, environmental, and economic impact of hormonally active contraceptives, a series of comprehensive literature surveys were employed. Sociological effects are discussed ...
Contraception/Comparison > Side Effects > Hormonal ContraceptionContraception/Comparison > FABM vs Hormonal > Side EffectsEthics/Philosophy > Informed Consent > Reproductive Procedures
Anderl C et al., 2021
Open Access
Journal of Child Psychology and Psychiatry, and Allied Disciplines
Background: Because of the widespread use of oral contraceptives (OCs) and the devastating effects of depression both on an individual and a societal level, it is crucial to understand the nature of t...
Skovlund CW et al., 2017The American Journal of Psychiatry
Objective: The purpose of this study was to assess the relative risk of suicide attempt and suicide in users of hormonal contraception.
Method: The authors assessed associations between hormonal contr...